Heartflow chief medical officer Campbell Rogers sells over $4.2 million in shares
Campbell Rogers, Chief Medical Officer at Heartflow Inc., sold shares valued at over $4.2 million between February and November 2026, according to a recent SEC filing. The sales, conducted under Rule 10b5-1 trading plans, included transactions at prices ranging from $24.40 to $55.01 per share, held indirectly by various trusts. Despite a 7.9% drop in HTFL stock over the past week, the company reported a 61% increase over the past year.
Analysts suggest the stock is overvalued, and there are no expectations of profitability this year. Additionally, Rogers acquired shares through the exercise of stock options totaling approximately $114,016, with exercise prices between $2.22 and $8.33 per share. Heartflow Inc. also reported strong Q3 2026 financials, with revenue of $72.9 million, surpassing estimates and showing robust growth.
Written by urgent.news from Investing.com's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.